1. Introduction {#sec1}
===============

The antineutrophil cytoplasmic antibody (ANCA) class of immunoglobulins features the principal subtypes c-ANCA and p-ANCA, which are predominantly generated against the cytosolic antigens proteinase 3 (PR3) and myeloperoxidase (MPO), respectively \[[@B1]\]. The presence of these autoantibodies has been described in a variety of autoimmune conditions, such as small-vessel vasculitides, ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis \[[@B2], [@B3]\]. Less frequently, ANCA induction can occur due to infections such as amebiasis, endocarditis, tuberculosis, malaria, human immunodeficiency virus infection, and hepatitis C virus (HCV) infection \[[@B2], [@B4]\]. Because autoimmune and infectious diseases may present similarly, ANCA positivity must be carefully interpreted \[[@B5]\]. The following case describes a 43-year-old male with chronically untreated HCV infection who was admitted to hospital with infective endocarditis and was found to be c-ANCA positive. We also summarize the literature concerning ANCA positivity in endocarditis and HCV infections.

2. Clinical Vignette {#sec2}
====================

A 43-year-old male with a history of HCV infection (untreated since his diagnosis six years previously, with an RNA viral load of 1584 IU/mL on admission) and intravenous polysubstance use presented to a medical center with acute fever, dyspnea, and arthralgia. He was found to have purpura over his edematous lower extremities. His initial laboratory investigations featured an elevated white blood cell count of 16 × 10^9^ cells per liter, elevated C-reactive protein of 183 mg/L, urinalysis that was positive for hematuria, and blood cultures that were later positive for methicillin-sensitive*Staphylococcus aureus*. He did feature transient acute kidney injury soon after admission (peak serum creatinine 283 umol/L). His serology was also positive for c-ANCA (anti-PR3), antinuclear antibody, and weakly positive for type III cryoglobulinemia. An echocardiogram revealed 1.1 × 1.3 cm tricuspid vegetation involving the anterior and septal leaflets. A computerized tomography scan of his chest illustrated multiple bilateral septic pulmonary emboli, bilateral pleural effusions, and an anterior mediastinal abscess. A punch biopsy of a purpuric lesion on his right shin, performed one week into antibiotic therapy as his purpura was resolving ([Figure 1(a)](#fig1){ref-type="fig"}), revealed mild perivascular inflammation with focally extravasated erythrocytes and hemosiderin deposits consistent with a mild or resolving purpuric process ([Figure 1(b)](#fig1){ref-type="fig"}). The patient demonstrated clinical improvement during a six-week course of cefazolin.

3. Discussion {#sec3}
=============

ANCA positivity may pose a diagnostic and therapeutic quandary in the face of patient presentation consistent with either a vasculitic or infectious process, particularly in the case of infective endocarditis \[[@B6]\].

A literature search of previously published cases concerning ANCA induction in infective endocarditis was performed via PubMed and Medline using the title and abstract entries "endocarditis" and "ANCA or antineutrophil cytoplasmic antibody," yielding 70 relevant cases \[[@B1], [@B5]--[@B39]\]. A recent publication by Ying et al. (2014) describes 13 of these cases in addition to a literature review of several other ones \[[@B38]\]. We have expanded on this review through the addition of 26 other cases ([Table 1](#tab1){ref-type="table"}).

A set of diagnostic aids between infective endocarditis and small-vessel vasculitis has been previously outlined ([Table 2](#tab2){ref-type="table"}) \[[@B11]\]. One similarity, for example, is acute renal failure, the prevalence of which in bacterial endocarditis is 30% and is a significant predictor of mortality \[[@B40]\]. Glomerulonephritis in infective endocarditis is either pauci-immune, postinfective, or subendothelial membranoproliferative \[[@B41]\], the etiology of which can usually be discerned by obtaining a kidney biopsy \[[@B11]\].

Another ANCA-associated infection present in our reported patient is HCV infection. Previously published cases of ANCA induction due to hepatitis C infection are also summarized ([Table 3](#tab3){ref-type="table"}) \[[@B6], [@B22], [@B42]--[@B54]\]. Our case report hence features two possible infections for c-ANCA induction, both of which likely also contributed to the patient\'s cryoglobulinemia. Because ANCA induction is more common in chronic infections \[[@B6]\], it argues for hepatitis C as the cause of this patient\'s ANCA positivity as opposed to the more acute infection*Staphylococcus aureus* endocarditis \[[@B55]\]. Had his ANCA status been checked after endocarditis recovery, ANCA induction due to endocarditis as opposed to hepatitis C would have also been supported by a normalized or negative ANCA titer \[[@B8]\].

4. Conclusion {#sec4}
=============

In light of its use in the diagnostic evaluation of vasculitis, a positive ANCA may allow for an infection to mislead a diagnostician down the path of autoimmune possibilities, particularly in the context of infective endocarditis. While clues may be drawn from clinical, laboratory, and radiological data to help differentiate infective endocarditis from vasculitis, obtaining blood cultures is of foremost importance. Making such a distinction will avoid the detrimental consequence of initiating immunosuppressive therapy against an infection masquerading as an inflammatory disease.

The authors recognize the pathologist Dr. Karen Naert (Foothills Medical Centre, Calgary, Alberta, Canada) as a contributor to this paper for her analysis of the pathology specimen and for supplying the histology image ([Figure 1(b)](#fig1){ref-type="fig"}).
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![(a) Photograph of the patient\'s resolving purpura involving his legs one week into antibiotic therapy. (b) Corresponding hematoxylin and eosin-stained histopathology at 20x magnification of a punch biopsy of one of the lesions on his leg, showing mild perivascular inflammation with focally extravasated erythrocytes consistent with a resolving purpuric process. No leukocytoclastic vasculitis was seen.](CJIDMM2016-3585860.001){#fig1}

###### 

Number of positive clinical and laboratory characteristics among all previously reported cases of ANCA-positive infective endocarditis^*∗*^.

  Patient characteristic                 Proportion among 70 reported patient cases
  -------------------------------------- --------------------------------------------
  Mean age (years)                       53.2
  Male/female                            54/16
  Valve involvement                      56/70
   Aortic                                22
   Mitral                                16
   Left-sided not otherwise specified    7
   Aortic plus mitral                    6
   Tricuspid                             5
   Pulmonary                             1
   Mitral plus pulmonary and tricuspid   1
   Ventricular septal defect             1
  Clinical features                       
   Fever                                 46
   Anemia                                34
   Splenomegaly                          19
   Nephropathy (GN or AKI)               43
   Arthralgia                            17
   Lower extremity edema                 23
   Rash                                  15
   Purpura                               11
   Cerebral infarction                   7
   Finger clubbing                       4
  Laboratory results                      
   PR3                                   52
   MPO                                   8
   PR3 + MPO                             7
   Hematuria                             49
   Proteinuria                           14
  Microbiology                            
   Positive blood culture                54/70
   Pathogen                               
     *Streptococcus*spp.                 28
     *Enterococcus*spp.                  7
     *Staphylococcus*spp.                10
     *Bartonella*spp.                    9
     *Neisseria*spp.                     1
     *Propionibacterium*spp.             1
     *Haemophilus*spp.                   1
     *Gemella*spp.                       1
     *Aggregatibacter*spp.               1

GN: glomerulonephritis; AKI: acute kidney injury; PR3: proteinase 3; MPO: myeloperoxidase; spp.: species.

^*∗*^This table, taken from Ying et al. (2014) with permission, expands the review from the original 44 patients to include 26 others \[[@B38]\].

###### 

Diagnostic aids for differentiating between infectious endocarditis and small-vessel vasculitis^*∗*^.

  Similarities^a^                                   Differences^b^
  ------------------------------------------------- --------------------------------------
  \(i\) Presentation with constitutional symptoms   \(i\) Splenomegaly
  \(ii\) Pyrexia                                    \(ii\) Thrombocytopenia
  \(iii\) Active urinary sediment                   \(iii\) Hypocomplementemia
  \(iv\) Skin involvement                           \(iv\) Immune complexes
  \(v\) Decreased GFR                               \(v\) Other positive autoantibodies
  \(vi\) Increased inflammatory marker levels       \(vi\) Low titer ANCA/ELISA negative
                                                    \(vii\) Other organ involvement

ANCA: antineutrophil cytoplasmic antibody; ELISA: enzyme-linked immunosorbent assay; GFR: glomerular filtration rate.

^a^Features seen in both conditions.

^b^Features seen predominantly in infectious endocarditis.

^*∗*^This table was taken from Forbes et al. (2012) with permission \[[@B11]\].

###### 

Summary of previously published ANCA-positive hepatitis C infection cases.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Paper                                             Age (years), sex      ANCA                                                        Miscellaneous features
  ------------------------------------------------- --------------------- ----------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bonaci-Nikolic et al., 2010 \[[@B6]\]             63, F                 MPO                                                         ---

  51, F                                             MPO                   ---                                                         

  24, F                                             MPO                   ---                                                         

                                                                                                                                      

  Cojocaru et al., 2007 \[[@B42]\]                  Mean 75               21 PR3                                                      Concomitant ischemic stroke

                                                                                                                                      

  Cojocaru et al., 2006 \[[@B43]\]                  ?                     ?                                                           ---

                                                                                                                                      

  Gatselis et al., 2006 \[[@B44]\]                  ?                     65 c-ANCA, 4 p-ANCA (though all negative for PR3 and MPO)    

                                                                                                                                      

  Lamprecht et al., 2003 \[[@B22]\]                 ?                     6 bactericidal/permeability-increasing proteins             Mixed cryoglobulinemia

  4 cathepsin G proteins                                                                                                              

  1 unknown antigen (c-ANCA)                                                                                                          

  2 bactericidal/permeability-increasing proteins   No cryoglobulinemia                                                               

  Four patients: cathepsin G                                                                                                          

                                                                                                                                      

  Zandman-Goddard et al., 2003 \[[@B45]\]           34, M                 c-ANCA and p-ANCA                                           Complicated by transverse myelitis

                                                                                                                                      

  Tajima et al., 2002 \[[@B46]\]                    66, F                 p-ANCA                                                      Complicated by pachymeningitis

                                                                                                                                      

  Wu et al., 2002 \[[@B47]\]                        ?                     253 PR3,\                                                   Higher proportion of ANCA-positive compared to ANCA-negative patients with high alanine aminotransferase, high alpha-fetoprotein, skin disease, cirrhosis, and anemia
                                                                          25 PR3 and MPO                                              

                                                                                                                                      

  Agarwal et al., 2001 \[[@B48]\]                   ?                     5 p-ANCA                                                    ---

                                                                                                                                      

  Igaki et al., 2000 \[[@B49]\]                     60, F                 MPO                                                         Glomerulonephritis, cryoglobulinemia

                                                                                                                                      

  Lamprecht et al., 1998 \[[@B50]\]                 60, F                 c-ANCA                                                      Type II cryoglobulinemia

                                                                                                                                      

  Ohira et al., 1998 \[[@B51]\]                     ?                     12 c-ANCA or p-ANCA                                         ---

                                                                                                                                      

  Kallinowski et al., 1997 \[[@B52]\]               ?                     5 ANCA                                                      ---

                                                                                                                                      

  Papi et al., 1997 \[[@B53]\]                      63, F                 MPO                                                         Mixed type II cryoglobulinemia, leukocytoclastic vasculitis on skin biopsy

                                                                                                                                      

  Dalekos and Tsianos, 1994 \[[@B54]\]              ?                     3 ANCA                                                      ---
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

F: female; ANCA: antineutrophil cytoplasmic antibody; MPO: myeloperoxidase; PR3: proteinase 3.
